{"id":8044,"date":"2025-02-19T09:41:45","date_gmt":"2025-02-19T09:41:45","guid":{"rendered":"https:\/\/els-solutions.com\/cms\/dev\/?p=8044"},"modified":"2025-02-26T11:15:41","modified_gmt":"2025-02-26T11:15:41","slug":"anvisa-updates-the-reference-medicines-list","status":"publish","type":"post","link":"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/","title":{"rendered":"Anvisa updates the Reference Medicines List."},"content":{"rendered":"<p data-pm-slice=\"1 1 []\">Anvisa has updated the <strong>The Reference Medicines List<\/strong>. The list is divided into groups that organize medicines based on their composition. Check the description of each group:<\/p>\n<ul class=\"ProsemirrorEditor-list\">\n<li class=\"ProsemirrorEditor-listItem\" data-list-indent=\"1\" data-list-type=\"bulleted\"><strong>Group A:<\/strong> Refers to medicines containing a <strong>single active pharmaceutical ingredient.<\/strong><\/li>\n<li class=\"ProsemirrorEditor-listItem\" data-list-indent=\"1\" data-list-type=\"bulleted\"><strong>Group B:<\/strong> Includes medicines with <strong>two or more active pharmaceutical ingredients<\/strong>, but in a <strong>single pharmaceutical form<\/strong>.<\/li>\n<li class=\"ProsemirrorEditor-listItem\" data-list-indent=\"1\" data-list-type=\"bulleted\"><strong>Group C:<\/strong> Includes medicines with <strong>two or more active pharmaceutical ingredients<\/strong>, in the same or different pharmaceutical forms, for <strong>concomitant or sequential use<\/strong>.<\/li>\n<\/ul>\n<p>Furthermore, to access the latest versions of the lists, see the updates below:<\/p>\n<ul class=\"ProsemirrorEditor-list\">\n<li class=\"ProsemirrorEditor-listItem\" data-list-indent=\"1\" data-list-type=\"bulleted\"><strong>List A<\/strong> &#8211; Updated on: <a href=\"https:\/\/www.gov.br\/anvisa\/pt-br\/setorregulado\/regularizacao\/medicamentos\/medicamentos-de-referencia\/arquivos\/lista-a-incluidos-05022025.pdf\">05\/02\/2025<\/a><\/li>\n<li class=\"ProsemirrorEditor-listItem\" data-list-indent=\"1\" data-list-type=\"bulleted\"><strong>List A &#8211; Excluded<\/strong> &#8211; Updated on: <a href=\"https:\/\/www.gov.br\/anvisa\/pt-br\/setorregulado\/regularizacao\/medicamentos\/medicamentos-de-referencia\/arquivos\/lista-a-excluidos-05022025.pdf\">05\/02\/2025<\/a><\/li>\n<li class=\"ProsemirrorEditor-listItem\" data-list-indent=\"1\" data-list-type=\"bulleted\"><strong>List B<\/strong> &#8211; Updated on: <a href=\"https:\/\/www.gov.br\/anvisa\/pt-br\/setorregulado\/regularizacao\/medicamentos\/medicamentos-de-referencia\/arquivos\/lista-b-incluidos-06012025.pdf\">06\/01\/2025<\/a><\/li>\n<li class=\"ProsemirrorEditor-listItem\" data-list-indent=\"1\" data-list-type=\"bulleted\"><strong>List B &#8211; Excluded<\/strong> &#8211; Update on:<a href=\"https:\/\/www.gov.br\/anvisa\/pt-br\/setorregulado\/regularizacao\/medicamentos\/medicamentos-de-referencia\/arquivos\/lista-b-excluidos-06012025.pdf\"> 06\/01\/2025<\/a><\/li>\n<\/ul>\n<p>This information is important for those who want to understand the different categories of medicines on the reference list.<\/p>\n<p data-start=\"0\" data-end=\"81\">If you need more information on <a href=\"https:\/\/els-solutions.com\/en\/?page_id=6445\">regulatory matters regarding the pharmaceutical sector<\/a>, <strong data-start=\"52\" data-end=\"59\">ELS<\/strong> can help.<\/p>\n<p data-start=\"83\" data-end=\"168\" data-is-last-node=\"\">Please contact your local <strong data-start=\"109\" data-end=\"116\">ELS<\/strong> consultant or email us at <strong data-start=\"143\" data-end=\"167\"><a rel=\"noopener\" data-start=\"145\" data-end=\"165\">info@elssolutions.pt<\/a><\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The National Health Surveillance Agency (ANVISA) has updated the Reference Drug List, which classifies medications into groups based on their composition.<\/p>\n","protected":false},"author":9,"featured_media":8046,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[101,100,54,102,95],"tags":[62,103],"class_list":["post-8044","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-anvisa-en","category-brazil","category-general","category-noticias-en","category-regulations","tag-news","tag-regulations"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Anvisa updates the The Reference Medicines List.<\/title>\n<meta name=\"description\" content=\"Anivsa has updated the Reference Drug List, which classifies medications into groups based on their composition.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anvisa updates the The Reference Medicines List.\" \/>\n<meta property=\"og:description\" content=\"Anivsa has updated the Reference Drug List, which classifies medications into groups based on their composition.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/\" \/>\n<meta property=\"og:site_name\" content=\"ELS Group - Accelerating Innovation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/els.solutions\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-19T09:41:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-26T11:15:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Groups-of-the-Reference-List-of-Medicines.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Marketing ELS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing ELS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/\"},\"author\":{\"name\":\"Marketing ELS\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\"},\"headline\":\"Anvisa updates the Reference Medicines List.\",\"datePublished\":\"2025-02-19T09:41:45+00:00\",\"dateModified\":\"2025-02-26T11:15:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/\"},\"wordCount\":168,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Groups-of-the-Reference-List-of-Medicines.png\",\"keywords\":[\"News\",\"regulations\"],\"articleSection\":[\"ANVISA`\",\"brazil\",\"General\",\"Not\u00edcias\",\"regulations\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/\",\"url\":\"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/\",\"name\":\"Anvisa updates the The Reference Medicines List.\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Groups-of-the-Reference-List-of-Medicines.png\",\"datePublished\":\"2025-02-19T09:41:45+00:00\",\"dateModified\":\"2025-02-26T11:15:41+00:00\",\"description\":\"Anivsa has updated the Reference Drug List, which classifies medications into groups based on their composition.\",\"breadcrumb\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/#primaryimage\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Groups-of-the-Reference-List-of-Medicines.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Groups-of-the-Reference-List-of-Medicines.png\",\"width\":1200,\"height\":600,\"caption\":\"Anvisa atualiza Lista de Medicamentos de Refer\u00eancia\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/els-solutions.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa updates the Reference Medicines List.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/els-solutions.com\/en\/#website\",\"url\":\"https:\/\/els-solutions.com\/en\/\",\"name\":\"ELS Group - Accelerating Innovation\",\"description\":\"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica\",\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/els-solutions.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\",\"name\":\"ELS Group - Accelerating Innovation\",\"url\":\"https:\/\/els-solutions.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"width\":2226,\"height\":1080,\"caption\":\"ELS Group - Accelerating Innovation\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/els.solutions\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\",\"name\":\"Marketing ELS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"caption\":\"Marketing ELS\"},\"sameAs\":[\"https:\/\/els-solutions.com\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anvisa updates the The Reference Medicines List.","description":"Anivsa has updated the Reference Drug List, which classifies medications into groups based on their composition.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Anvisa updates the The Reference Medicines List.","og_description":"Anivsa has updated the Reference Drug List, which classifies medications into groups based on their composition.","og_url":"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/","og_site_name":"ELS Group - Accelerating Innovation","article_publisher":"https:\/\/www.facebook.com\/els.solutions\/","article_published_time":"2025-02-19T09:41:45+00:00","article_modified_time":"2025-02-26T11:15:41+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Groups-of-the-Reference-List-of-Medicines.png","type":"image\/png"}],"author":"Marketing ELS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marketing ELS","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/#article","isPartOf":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/"},"author":{"name":"Marketing ELS","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3"},"headline":"Anvisa updates the Reference Medicines List.","datePublished":"2025-02-19T09:41:45+00:00","dateModified":"2025-02-26T11:15:41+00:00","mainEntityOfPage":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/"},"wordCount":168,"commentCount":0,"publisher":{"@id":"https:\/\/els-solutions.com\/en\/#organization"},"image":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Groups-of-the-Reference-List-of-Medicines.png","keywords":["News","regulations"],"articleSection":["ANVISA`","brazil","General","Not\u00edcias","regulations"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/","url":"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/","name":"Anvisa updates the The Reference Medicines List.","isPartOf":{"@id":"https:\/\/els-solutions.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/#primaryimage"},"image":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Groups-of-the-Reference-List-of-Medicines.png","datePublished":"2025-02-19T09:41:45+00:00","dateModified":"2025-02-26T11:15:41+00:00","description":"Anivsa has updated the Reference Drug List, which classifies medications into groups based on their composition.","breadcrumb":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/#primaryimage","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Groups-of-the-Reference-List-of-Medicines.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Groups-of-the-Reference-List-of-Medicines.png","width":1200,"height":600,"caption":"Anvisa atualiza Lista de Medicamentos de Refer\u00eancia"},{"@type":"BreadcrumbList","@id":"https:\/\/els-solutions.com\/en\/anvisa-updates-the-reference-medicines-list\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/els-solutions.com\/en\/"},{"@type":"ListItem","position":2,"name":"Anvisa updates the Reference Medicines List."}]},{"@type":"WebSite","@id":"https:\/\/els-solutions.com\/en\/#website","url":"https:\/\/els-solutions.com\/en\/","name":"ELS Group - Accelerating Innovation","description":"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/els-solutions.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/els-solutions.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/els-solutions.com\/en\/#organization","name":"ELS Group - Accelerating Innovation","url":"https:\/\/els-solutions.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","width":2226,"height":1080,"caption":"ELS Group - Accelerating Innovation"},"image":{"@id":"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/els.solutions\/"]},{"@type":"Person","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3","name":"Marketing ELS","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","caption":"Marketing ELS"},"sameAs":["https:\/\/els-solutions.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/8044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/comments?post=8044"}],"version-history":[{"count":2,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/8044\/revisions"}],"predecessor-version":[{"id":8143,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/8044\/revisions\/8143"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/media\/8046"}],"wp:attachment":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/media?parent=8044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/categories?post=8044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/tags?post=8044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}